Zacks.com on MSN3d
Sanofi Inks $1.9B Deal With Dren Bio to Buy Autoimmune Disease DrugThrough the Dren Bio deal, SNY intends to expand its immunology pipeline and establish itself as a leading immunology company ...
The panel voted 21 to zero that Beyfortus (nirsevimab) appears to be safe and effective at preventing RSV infections in newborns and infants as they face their first RSV season, setting the drug ...
If approved by the 10th June action date, clesrovimab could start competing with Sanofi and AstraZeneca's fast-growing Beyfortus (nirsevimab) – which got the go-ahead from the US regulator in ...
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...
After hours: 17 March at 7:53:12 pm GMT-4 Loading Chart for AZN ...
Health care providers including hospitals can order publicly funded vaccines for their clients via Toronto Public Health (TPH). The process differs by product. Please read the eligibility criteria and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback